APA (7th ed.) Citation

J, C., T, W., KM, K., I, F., S, R., S, A., . . . KE, Y. (2025). Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment. MedRxiv : the preprint server for health sciences. https://doi.org/10.1101/2025.04.05.25325203

Chicago Style (17th ed.) Citation

J, Coppinger, West T, Kirmess KM, Fogelman I, Ray S, Aurora S, Verghese PB, Braunstein JB, and Yarasheski KE. "Independent Validation of the PrecivityAD2™ Blood Test to Identify Presence or Absence of Brain Amyloid Pathology in Individuals with Cognitive Impairment." MedRxiv : The Preprint Server for Health Sciences 2025. https://doi.org/10.1101/2025.04.05.25325203.

MLA (9th ed.) Citation

J, Coppinger, et al. "Independent Validation of the PrecivityAD2™ Blood Test to Identify Presence or Absence of Brain Amyloid Pathology in Individuals with Cognitive Impairment." MedRxiv : The Preprint Server for Health Sciences, 2025, https://doi.org/10.1101/2025.04.05.25325203.